Evidence map›Paper›PMID 29247066›Full record

ArticleGut2018

Hidekazu Suzuki, Juntaro Matsuzaki

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Gut, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Environmental factors in gastric carcinogenesis and preventive intervention strategies.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2025
    Review
  2. Cost-effectiveness analysis of two routine therapeutic methods forGastroenterology and hepatology from bed to bench · 2021
    Article
  3. Article
  4. Proton pump inhibitor: The dual role in gastric cancer.World journal of gastroenterology · 2019
    Review
  5. Rifabutin and Furazolidone Could Be the Candidates of the Rescue Regimen for Antibiotic-ResistantThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2019
    Article
  6. Gastric cancer: evidence boosts Helicobacter pylori eradication.Nature reviews. Gastroenterology & hepatology · 2018
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hidekazu SuzukiFellowship Training Center, Medical Education Center, Keio University School of Medicine, Tokyo, Japan.
Juntaro MatsuzakiDivision of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan.
Keio University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Helicobacter pyloriProton Pump InhibitorsAnti-Bacterial AgentsDyspepsiaHelicobacter InfectionsHumansStomach NeoplasmsAnti-Bacterial AgentsProton Pump Inhibitorsdyspepsiagastric cancerhelicobacter pylori - gastritishelicobacter pylori - treatmentproton pump inhibition

Identifiers

PMID29247066
OpenAlexW2775432407

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.